| Literature DB >> 31766520 |
Esperanza Díaz1,2, M Lt Sup Gt A Lt/Sup Gt Blanca Valle3, Sylvie Ribeiro4,5, Senentxu Lanceros-Mendez2,4,6, José Manuel Barandiarán2,3.
Abstract
A study of Magnetite (Fe3O4) as a suitable matrix for the improved adhesion and proliferation of MC3T3-E1 pre-osteoblast cells in bone regeneration is presented. Biodegradable and magnetic polycaprolactone (PCL)/magnetite (Fe3O4) scaffolds, which were fabricated by Thermally Induced Phase Separation, are likewise analyzed. Various techniques are used to investigate in vitro degradation at 37 °C, over 104 weeks, in a phosphate buffered saline (PBS) solution. Magnetic measurements that were performed at physiological temperature (310 K) indicated that degradation neither modified the nature nor the distribution of the magnetite nanoparticles. The coercive field strength of the porous matrices demonstrated ferromagnetic behavior and the probable presence of particle interactions. The added nanoparticles facilitated the absorption of PBS, with no considerable increase in matrix degradation rates, as shown by the Gel Permeation Chromatography (GPC) results for Mw, Mn, and I. There was no collapse of the scaffold structures that maintained their structural integrity. Their suitability for bone regeneration was also supported by the absence of matrix cytotoxicity in assays, even after additions of up to 20% magnetite.Entities:
Keywords: PCL; cytotoxicity; in vitro degradation; magnetism; magnetite; scaffolds
Year: 2019 PMID: 31766520 PMCID: PMC6926959 DOI: 10.3390/ma12233843
Source DB: PubMed Journal: Materials (Basel) ISSN: 1996-1944 Impact factor: 3.623
Figure 1(a) Magnetization curves of PCL-nFe3O4. (b) Magnetization curves of PCL-10%nFe3O4 before and after 20 weeks degradation.
Magnetization at 1.5 Tesla relative to the nominal content of nFe3O4, coercive field, and actual content of nFe3O4 recalculated from the measurements. Estimated errors are displayed in brackets and refer to the variation of the last significative figure.
| % nFe3O4 | Magnetization at 1.5T | µ0 Hc (mT) | %nFe3O4 |
|---|---|---|---|
| 100 * | 82 (2) | 11.9 (2) | - |
| 5 | 78 (2) | 12.0 (2) | 4.8 (1) |
| 10 | 81 (2) | 11.9 (2) | 9.9 (2) |
| 15 | 75 (1) | 11.1 (2) | 13.8 (3) |
| 20 | 69 (1) | 11.4 (2) | 16.8 (4) |
* Pure nFe3O4 serving as a reference.
Figure 2Fourier-Transform Infrared (FTIR) spectra of PCL-n Fe3O4.
Figure 3(a) Spectra of PCL-5% nFe3O4 after various degradation times. (b) FTIR spectra of PCL-10% nFe3O4 after various degradation times.
Parameters obtained by DSC on the PCL-nFe3O4 scaffolds: Tm = melting point (°C), ΔHm = melting enthalpy (kJ/kg), Tc = crystallization temperature (°C), ΔHc = crystallization enthalpy (kJ/kg), Tg = glass transition temperature (°C), Xc = crystalline fraction (%), calculated as Xc% = [(ΔHm1 − ΔHc)/ΔHmo] × 100% with ΔHmo = 139.5 J·g−1, CF% = (ΔHc/ΔHm1) × 100%.
| Sample | 1st Run | 2nd Run | 3rd Run | Tg (°C) | Xc% | CF% | |||
|---|---|---|---|---|---|---|---|---|---|
| Tm1 (°C) | ΔHm1 | Tc | ΔHc | Tm2 (°C) | ΔHm2 | ||||
| 0%nFe3O4 | 60 | 107.4 | 26 | 64.7 | 57 | 83.2 | −59 | 77 | 60.2 |
| 5%nFe3O4 0dt | 60 | 94.6 | 30 | 60.2 | 58 | 74.1 | −59 | 68 | 64 |
| 4dt | 63 | 93.9 | 31 | 59.2 | 57 | 65.6 | −58.5 | 67 | 63 |
| 8dt | 64 | 88.7 | 30.5 | 58.6 | 58 | 65.4 | −60 | 64 | 66 |
| 16dt | 63 | 90 | 30 | 58.1 | 58 | 65.4 | −63 | 65 | 65 |
| 20dt | 67 | 80.5 | 31.5 | 53 | 56.5 | 72.9 | −63 | 58 | 65 |
| 25dt | 67 | 77.7 | 31 | 52.4 | 56 | 68.5 | −63 | 56 | 67 |
| 104dt | 65 | 90.2 | 31 | 57.4 | 58 | 59.7 | −64 | 65 | 64 |
| 10%nFe3O4 0dt | 59 | 92.2 | 31 | 59.9 | 56 | 73.6 | −59 | 66 | 65 |
| 4dt | 63 | 67 | 31 | 47.2 | 57.5 | 49 | −58 | 48 | 70 |
| 8dt | 64 | 91 | 31 | 59.3 | 58 | 66.9 | −61 | 65 | 65 |
| 16dt | 63 | 80.2 | 31 | 49.7 | 58 | 64.4 | −58 | 57 | 62 |
| 20dt | 66 | 77.5 | 30.5 | 49.4 | 55.5 | 57.6 | −63 | 56 | 62 |
| 25dt | 67 | 76.9 | 32 | 48 | 56 | 54.7 | −63 | 55 | 62 |
| 104dt | 65 | 94.3 | 31 | 55.4 | 57 | 62.2 | −63 | 68 | 59 |
| 15%nFe3O4 0dt | 59 | 83.1 | 30 | 52 | 59 | 69.7 | −58 | 60 | 63 |
| 20%nFe3O4 0dt | 58 | 81.3 | 30 | 51 | 58 | 65.9 | −58 | 58 | 63 |
Figure 4(a) Thermograms of PCL-5%nFe3O4 after various degradation times. (b) Thermograms of PCL-10%nFe3O4 after various degradation times.
Figure 5(a) Scanning electron microscopy (SEM) micrograph of magnetite nanoparticles. (b) TEM micrograph of magnetite nanoparticles. (c) SEM micrograph of poly(ε-caprolactone) (PCL) scaffold.
Figure 6SEM observation of Surface morphology of PCL ×500. (a) PCL-5% nFe3O4. (b) PCL-5% nFe3O4 after in vitro degradation for 8 weeks. (c) PCL-5% nFe3O4 after in vitro degradation for 25 weeks. (d) PCL-10% nFe3O4. (e) PCL-10 % nFe3O4 after in vitro degradation for 16 weeks. (f) PCL-10 % nFe3O4 after in vitro degradation for 25 weeks.
Figure 7(a) Water absorption by PCL-5%nFe3O4 and PCL-10%nFe3O4 matrices vs. degradation time; (b) pH of the PBS solution vs. degradation time.
Molecular weight: weight average (Mw), number average (Mn), and polydispersity index I of the PCL-nFe3O4 system.
| Sample | Degradation Time (Weeks) | Mw | Mn | I |
|---|---|---|---|---|
| PCL | 0 | 134418 | 92103 | 1.459 |
| PCL-5%nFe3O4 | 25 | 143410 | 97073 | 1.477 |
| 104 | 99888 | 61754 | 1.617 | |
| PCL-10%nFe3O4 | 25 | 139433 | 90264 | 1.545 |
| 104 | 86212 | 54070 | 1.594 | |
| PCL-15%nFe3O4 | 0 | 134441 | 95866 | 1.402 |
Figure 8Cell Viability of MC3T3-E1 pre-osteoblast cell line in contact with the conditioned medium exposed with different samples after 24 and 72 h.